Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1978-03-06
1979-09-18
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
424 99, A61K 31415
Patent
active
041683161
ABSTRACT:
By isolation and purification from the urine of patients treated with niridazole there is obtained substantially pure 1-(thiocarbamoyl)-2-imidazolidinone which exhibits marked immunosuppressive activity. A particular isolation procedure is described in addition to a chemical synthesis as follows: ##STR1##
REFERENCES:
chemical Abstracts, vol. 86:150570a; 1977 citing Lucas et al., J. Immunol. 1977, 118 (2), pp. 418-422.
Daniels et al., The Journal of Immunology, vol. 115, No. 5, Nov. 1975, pp. 1414-1421.
Helv. Chem. Acta., vol. 49, pp. 2443-2452 (1966).
The Condensed Chem. Dictionary, 6th Ed., p. 395, Reinhold Pub. Corp., N.Y., May 4, 1964.
Warren Kenneth S.
Webster, Jr. Leslie T.
Case Western Reserve University
Moyer Donald B.
Northwestern University
LandOfFree
Immunosuppressive-1-(thiocarbamoyl)-2-imidazolidinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunosuppressive-1-(thiocarbamoyl)-2-imidazolidinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppressive-1-(thiocarbamoyl)-2-imidazolidinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897813